TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/NTLX

NeuroThera Labs Inc. (NTLX : TSX-V)

Common Stock

$0.33

CAD

+0.04 (12.07%)

Last updated: 2026-08-11

Get NTLX alerts:

NTLX

NeuroThera Labs Inc.

Source:WealthAwesomeWealthAwesome
$0.15 (80.56%)
30 day period
$0.16$0.24$0.33Jun 3Jun 24Aug 11

Performance

1 Day

+0.00%

1 Week

+47.73%

1 Month

+91.18%

YTD

+91.18%

Key Statistics

Market Cap

$27.59M

52W High

$0.33

52W Low

$0.15

P/E Ratio

-

50 Day MA

$0.19

200 Day MA

$0.19

Beta

-0.20

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
8/11/2026$0.30$0.33$0.30$0.33$0.33102,000
8/7/2026$0.23$0.29$0.23$0.29$0.2956,000
8/6/2026$0.24$0.24$0.24$0.24$0.2425,000
7/31/2026$0.22$0.22$0.22$0.22$0.2220,000
7/30/2026$0.23$0.24$0.23$0.24$0.2432,500
7/29/2026$0.20$0.23$0.20$0.23$0.23122,000
7/28/2026$0.20$0.20$0.20$0.20$0.20584,000
7/27/2026$0.20$0.20$0.20$0.20$0.2057,000
7/3/2026$0.16$0.17$0.16$0.17$0.1763,500
7/2/2026$0.16$0.16$0.16$0.16$0.1650,000

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on NTLX's historical volatility

HistoricalForecast68%95%
C$0.10C$0.37C$0.65C$0.92C$1.19C$1.46TodayMar 5May 11Aug 11Sep 23Nov 6Dec 19

30-Day Vol

108.3%

Annualized

90-Day Vol

147.6%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.39

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.34C$0.24C$0.50
60 trading daysC$0.37C$0.22C$0.62
90 trading daysC$0.39C$0.20C$0.74

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About NeuroThera Labs Inc.

Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.

Financials

Revenue (TTM)
$856,000
EBITDA
$-2.54M
Profit Margin
0.00%
ROE (TTM)
-399.18%
EPS (Diluted)
-0.09
Book Value
0.00

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About NTLX

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
WMSWestern Metallica Resources Corp.$0.20+66.67%
BECNBEACN Wizardry & Magic Inc$0.04+60.00%
CLZCanasil Resources Inc.$0.04+50.00%
KNEKane Biotech Inc$0.03+50.00%
PULPulse Oil Corp$0.01+50.00%
WECWinchester Equity Corporation$0.01+50.00%
BBCM Resources Corp$0.68+40.21%
BITKBlockchaink2 Corp$0.04+40.00%

NTLX.V news timeline

1 article covering NTLX.V, most recent first

Latest

TSX & TSXV small caps leading the week — August 13, 2026

Investing

Advertisement